Insider trades

Sigal Charles Elliott

Sigal Charles Elliott made 1 buy and 0 sales on the open market in the last 12 months at Alnylam Pharmaceuticals, Inc. and Vir Biotechnology, Inc. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
Director3,600Nov 10, 2026
Vir Biotechnology, Inc.
NASDAQ:VIR
Director39,806May 27, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
Nov 10, 2026Buy1,600US$152.25US$244K3,600Nov 12, 2026